baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JTC PLC/ JE00BF4X3P53 /

2024-11-12 5:29:54 PM	Chg. -22.50	Volume	Bid5:30:00 PM	Ask5:30:00 PM	High	Low
968.50GBX	-2.27%	17,306 Turnover(GBP): 168,940.9000	-Bid Size: -	-Ask Size: -	990.00	968.50

GlobeNewswire 08-27 Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 08-27 COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Chil...

GlobeNewswire 08-22 Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

GlobeNewswire 08-21 Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual...

GlobeNewswire 08-20 Juventus Football Club Announces Fortinet as Its Official Cybersecurity Partner

GlobeNewswire 08-20 AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Amp...

GlobeNewswire 08-19 Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiat...

GlobeNewswire 08-19 Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 08-16 AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08-14 Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corpora...

GlobeNewswire 08-14 GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08-14 Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...

GlobeNewswire 08-13 AIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Confere...

GlobeNewswire 08-13 Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08-13 COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire 08-13 Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near...

GlobeNewswire 08-12 Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

GlobeNewswire 08-08 Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis

GlobeNewswire 08-07 Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2...

GlobeNewswire 08-07 Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

GlobeNewswire 08-02 Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

GlobeNewswire 07-31 Palisade Bio Participates in Virtual Investor “What this Means” Segment

GlobeNewswire 07-30 Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024

GlobeNewswire 07-29 AIM ImmunoTech Announces Release of the Next CEO Corner Segment

GlobeNewswire 07-29 Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...

JTC PLC/ JE00BF4X3P53 /

If you wish to receive reply to your feedback, please provide your email address.